Taking a Deep Dive into Subjective Cognitive Decline

Dementia Matters by Wisconsin Alzheimer‘s Disease Research Center

Jul 7, 202617:04Science & Medicine

Dr. Jessen returns to the podcast to take a deeper dive into subjective cognitive decline (SCD). Aiming to cover everything relating to SCD, Dr. Jessen shares insights in prognosis, risk factors and how SCD should be add...

Related Episodes

Continue listening to more episodes from Dementia Matters.

Blood Tests and Brain Scans and Biomarkers, Oh My! How Biomarkers are Changing Alzheimer’s Disease Clinical Trials

Sep 8, 2026 - 45:21

In recent years, the U.S. Food and Drug Administration (FDA) has approved new biomarker tools for Alzheim...

New Alzheimer’s Association Special Report Breaks Down How Americans Understand and Support their Brain Health

Aug 25, 2026 - 37:00

In recent years, public interest in brain health has increased. So how are Americans understanding brain...

Reflecting on 25 Years of the Wisconsin Registry for Alzheimer’s Prevention

Aug 12, 2026 - 35:54

Twenty-five years ago, a single participant enrolled in what would become the Wisconsin Registry for Alzh...

How Dementia Caregiving Affects the Spousal Caregiver

Jul 28, 2026 - 39:06

Caring for those with dementia represents a major public health challenge, with caregivers, especially sp...

Managing the Medicine Cabinet: How Prescriptions Impact Cognition and Brain Health as We Age

Jul 14, 2026 - 35:04

Prescription medications, over-the-counter drugs and supplements are incredibly common among older adults...

Defining Subjective Cognitive Decline

Jun 30, 2026 - 30:02

Subjective cognitive decline (SCD) can be one of the earliest noticeable signs of Alzheimer's disease, ye...

SPRINT to a Healthy Mind: How Blood Pressure Control Affects Brain Health and Dementia Risk

Jun 18, 2026 - 40:02

Geriatrician Dr. Mark Supiano joins the podcast to discuss the connection between heart and brain health....

Addressing Cochrane’s Review on Amyloid-Targeting Treatments for Alzheimer’s Disease

Jun 4, 2026 - 44:14

Amyloid-targeting monoclonal antibody treatments have ushered in a new era of Alzheimer’s disease therapi...